We are live on ! Find out more
LG

LaFleur & Godfrey Portfolio holdings

AUM $842M
1-Year Est. Return 24.12%
This Fund
S&P 500
This Quarter Est. Return
-3.58%
1 Year Est. Return
+24.12%
3 Year Est. Return
+85.19%
5 Year Est. Return
+109.34%
10 Year Est. Return
+386.09%
AUM
$744M
AUM Growth
-$35.5M
Cap. Flow
+$1.91M
Cap. Flow %
0.26%
Top 10 Hldgs %
37.02%
Holding
137
New
10
Increased
51
Reduced
49
Closed
5

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$3.42M
2
ZS icon
Zscaler
ZS
+$2.67M
3
MRVL icon
Marvell Technology
MRVL
+$2.64M
4
MU icon
Micron Technology
MU
+$2.48M
5
DIS icon
Walt Disney
DIS
+$2.47M

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$4.56M
2
JNJ icon
Johnson & Johnson
JNJ
+$2.44M
3
VZ icon
Verizon
VZ
+$2.2M
4
GS icon
Goldman Sachs
GS
+$1.85M
5
MMM icon
3M
MMM
+$1.67M

Sector Composition

Rank Sector Weight
1 Technology 28.11%
2 Healthcare 26.91%
3 Industrials 10.03%
4 Miscellaneous 8.12%
5 Consumer Staples 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$60.3M 8.09%
345,074
-3,549
-1% -$597K
VCSH icon
2
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$33.6M 4.52%
430,885
-20,511
-5% -$1.63M
MSFT icon
3
Microsoft
MSFT
$3.81T
$33.5M 4.5%
108,689
+2,243
+2% +$675K
JPM icon
4
JPMorgan Chase
JPM
$951B
$26.2M 3.52%
192,200
+2,872
+2% +$424K
SYK icon
5
Stryker
SYK
$127B
$23.9M 3.22%
89,552
-2,003
-2% -$518K
JNJ icon
6
Johnson & Johnson
JNJ
$646B
$21.6M 2.9%
121,726
-14,362
-11% -$2.44M
TMO icon
7
Thermo Fisher Scientific
TMO
$230B
$19.8M 2.66%
33,528
-40
-0.1% -$23K
ABBV icon
8
AbbVie
ABBV
$451B
$19.7M 2.65%
121,717
-6,017
-5% -$874K
PAYX icon
9
Paychex
PAYX
$45.2B
$18.8M 2.52%
137,427
-938
-0.7% -$115K
MRVL icon
10
Marvell Technology
MRVL
$195B
$18.2M 2.44%
253,208
+36,671
+17% +$2.64M
ALC icon
11
Alcon
ALC
$34.8B
$16.8M 2.26%
211,928
-6,618
-3% -$512K
ECL icon
12
Ecolab
ECL
$80.4B
$16M 2.15%
90,437
+1,151
+1% +$216K
INTC icon
13
Intel
INTC
$473B
$15.3M 2.05%
307,747
+68,966
+29% +$3.42M
RTX icon
14
RTX Corp
RTX
$285B
$15.2M 2.05%
153,805
+216
+0.1% +$20.5K
STE icon
15
Steris
STE
$22.8B
$14.5M 1.95%
60,050
-1,211
-2% -$281K
BMY icon
16
Bristol-Myers Squibb
BMY
$136B
$13.3M 1.79%
182,218
-580
-0.3% -$38.9K
MRK icon
17
Merck
MRK
$366B
$13.1M 1.75%
159,113
+2,238
+1% +$176K
WSO icon
18
Watsco Inc
WSO
$12.8B
$12.7M 1.71%
41,847
-214
-0.5% -$61K
VMC icon
19
Vulcan Materials
VMC
$35.6B
$12.6M 1.69%
68,356
-3,137
-4% -$586K
CAT icon
20
Caterpillar
CAT
$368B
$12.3M 1.65%
55,255
-2,162
-4% -$453K
FSLR icon
21
First Solar
FSLR
$22B
$11.9M 1.6%
141,921
+24,181
+21% +$1.85M
WWD icon
22
Woodward
WWD
$20.2B
$11.6M 1.55%
92,645
+120
+0.1% +$14.1K
HOLX
23
DELISTED
Hologic
HOLX
$11.4M 1.54%
148,941
+1,130
+0.8% +$81.3K
MDT icon
24
Medtronic
MDT
$117B
$11.4M 1.53%
102,839
+15,377
+18% +$1.62M
PEP icon
25
PepsiCo
PEP
$193B
$11.4M 1.52%
67,813
+997
+1% +$167K

Similar funds

LaFleur & Godfrey's Q1 2022 Portfolio in Review

As of Q1 2022, LaFleur & Godfrey held 137 positions worth $744M, down 4.6% from $780M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

LaFleur & Godfrey's Q1 2022 filing shows 10 new, 51 increased, 49 reduced and 5 closed positions. Its largest new stake was Vanguard Short-Term Treasury ETF: 6,660 shares worth $395K. The largest sale was Teladoc Health, an estimated $4.56M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.

  • LaFleur & Godfrey's largest Q1 2022 buy was Vanguard Short-Term Treasury ETF: 6,660 shares worth $395K.
  • LaFleur & Godfrey added most to Intel in Q1 2022, an estimated $3.42M increase.
  • LaFleur & Godfrey's biggest Q1 2022 reduction was Teladoc Health, cutting an estimated $4.56M.
  • LaFleur & Godfrey fully exited ProShares Short S&P500 in Q1 2022, selling an estimated $419K.
  • LaFleur & Godfrey's ten largest holdings make up 37% of its $744M portfolio in Q1 2022.
  • LaFleur & Godfrey opened 10 new positions and closed 5 in Q1 2022.
  • LaFleur & Godfrey's portfolio value fell 4.6% quarter-over-quarter to $744M.

Based on LaFleur & Godfrey's 13F filing for Q1 2022, filed 3 May 2022.